Abacus FCF Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.86M | Sell |
13,821
-49,005
| -78% | -$17.5M | 1.09% | 46 |
|
|
2025
Q4 | $20.6M | Buy |
62,826
+1,460
| +2% | +$463K | 2.69% | 7 |
|
|
2025
Q3 | $17.3M | Sell |
61,366
-735
| -1% | -$213K | 2.3% | 14 |
|
|
2025
Q2 | $17.3M | Buy |
62,101
+43,068
| +226% | +$12.2M | 2.43% | 14 |
|
|
2025
Q1 | $5.93M | Buy |
19,033
+517
| +3% | +$153K | 0.93% | 38 |
|
|
2024
Q4 | $4.83M | Buy |
18,516
+5,828
| +46% | +$1.73M | 0.64% | 45 |
|
|
2024
Q3 | $4.09M | Buy |
+12,688
| New | +$4.15M | 0.95% | 27 |
|
|
2024
Q1 | – | Sell |
-8,595
| Closed | -$2.48M | – | 148 |
|
|
2023
Q4 | $2.48M | Buy |
8,595
+3,969
| +86% | +$1.08M | 0.72% | 41 |
|
|
2023
Q3 | $1.24M | Buy |
4,626
+3,458
| +296% | +$863K | 0.66% | 51 |
|
|
2023
Q2 | $259K | Sell |
1,168
-8,979
| -88% | -$2.08M | 0.13% | 133 |
|
|
2023
Q1 | $2.45M | Buy |
10,147
+3,417
| +51% | +$839K | 1.31% | 11 |
|
|
2022
Q4 | $1.77M | Sell |
6,730
-150
| -2% | -$40.2K | 1.15% | 16 |
|
|
2022
Q3 | $1.55M | Sell |
6,880
-2,399
| -26% | -$582K | 1.07% | 13 |
|
|
2022
Q2 | $2.26M | Sell |
9,279
-9,101
| -50% | -$2.23M | 1.38% | 11 |
|
|
2022
Q1 | $4.45M | Buy |
18,380
+8,271
| +82% | +$1.9M | 1.49% | 7 |
|
|
2021
Q4 | $2.27M | Hold |
10,109
| – | – | 1.12% | 18 |
|
|
2021
Q3 | $2.16M | Hold |
10,109
| – | – | 1.05% | 19 |
|
|
2021
Q2 | $2.45M | Sell |
10,109
-748
| -7% | -$184K | 1.25% | 8 |
|
|
2021
Q1 | $2.75M | Buy |
+10,857
| New | +$2.59M | 1.4% | 7 |
|
|
2019
Q1 | – | Sell |
-5,030
| Closed | -$979K | – | 97 |
|
|
2018
Q4 | $979K | Buy |
+5,030
| New | +$981K | 0.9% | 84 |
|
|
2017
Q3 | $275K | Buy |
1,476
+216
| +17% | +$38.3K | 0.86% | 91 |
|
|
2017
Q2 | $217K | Buy |
1,260
+648
| +106% | +$105K | 0.84% | 91 |
|
|
2017
Q1 | $100K | Buy |
612
+288
| +89% | +$47.9K | 0.83% | 90 |
|
|
2016
Q4 | $47K | Buy |
324
+184
| +131% | +$27.7K | 0.78% | 96 |
|
|
2016
Q3 | $23K | Sell |
140
-10,222
| -99% | -$1.73M | 0.92% | 96 |
|
|
2016
Q2 | $1.58M | Sell |
10,362
-1,205
| -10% | -$187K | 1.02% | 47 |
|
|
2016
Q1 | $1.73M | Sell |
11,567
-3,320
| -22% | -$493K | 0.99% | 55 |
|
|
2015
Q4 | $2.42M | Buy |
14,887
+274
| +2% | +$43.1K | 1.11% | 12 |
|
|
2015
Q3 | $2.02M | Buy |
+14,613
| New | +$2.3M | 1.04% | 72 |
|
|
2015
Q2 | – | Sell |
-13,260
| Closed | -$2.12M | – | 96 |
|
|
2015
Q1 | $2.12M | Buy |
+13,260
| New | +$2.09M | 1.04% | 78 |
|
Other funds holding AMGN
VCM
VPM
Abacus FCF Advisors's AMGN Position: Q1 2026 in Review
Abacus FCF Advisors reduced its Amgen (AMGN) stake by 78% in Q1 2026, selling an estimated $17.5M and leaving 13,821 shares worth $4.86M. The position accounts for 1.09% of the portfolio, ranked #46.
Abacus FCF Advisors first reported a position in AMGN in Q1 2015 and has held it in 30 quarters since. The position peaked at $20.6M in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Abacus FCF Advisors held 13,821 shares of Amgen worth $4.86M as of Q1 2026.
- Abacus FCF Advisors sold 49,005 Amgen shares in Q1 2026, an estimated $17.5M.
- Amgen made up 1.09% of Abacus FCF Advisors's portfolio in Q1 2026, its #46 holding.
- Abacus FCF Advisors first reported a position in Amgen in Q1 2015 and has held it in 30 quarters since.
- Abacus FCF Advisors's Amgen position peaked at $20.6M in Q4 2025.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Abacus FCF Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.